Clark Estates Inc Lannett CO Inc Transaction History

Clark Estates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$13.3 - $17.45 $1.6 Million - $2.1 Million	-120,500 Closed	0 $0
Q1 2018 Apr 18, 2018	BUY	$14.7 - $24.95 $367,500 - $623,750	25,000 Added 26.18%	120,500 $1.93 Million
Q3 2017 Oct 16, 2017	BUY	$15.1 - $19.25 $1.44 Million - $1.84 Million	95,500	95,500 $1.76 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

Stay updated on Clark Estates Inc with notifications on news.